- Article
Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes
- Juan José Fernández-Miranda,
- Silvia Díaz-Fernández,
- Francisco Javier Cepeda-Piorno and
- Francisco López-Muñoz
This research studies the dose–plasma level (PL) relationship of second-generation antipsychotics, together with the treatment outcomes achieved, in seriously ill people with schizophrenia. An observational, prospective, one-year follow-up stud...